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An acidic polysaccharide of Panax ginseng (APG), so
called ginsan is known to have important immuno-
modulatory activities. It was recently reported that APG
has radioprotective effects in mice but the detailed
mechanism was not fully elucidated. This study examined
the effects of APG on bone marrow cells (BMs). The
phenotypical and functional changes in APG-treated BMs
after gamma radiation were studied. The benefit of APG
on BMs damaged by gamma radiation was determined by
measuring the cell viability. Using 2 different assays, a
pretreatment with APG significantly increased the viability
of BMs against gamma radiation. APG-treated BMs had
a significantly higher amount of IL-12, which is a major
cytokine for immune responses, compared with the
medium-treated BMs. The expression of MHC class II
molecules of APG-treated BMs was also increased, and
APG-treated BMs showed significantly higher levels of
allogeneic CD4
+ T lymphocyte proliferation. Furthermore,
APG-treated mice had a larger number of BMs after
gamma radiation than the control mice, and the BMs of
APG-treated mice were successfully cultured into
dendritic cells, which are the representative antigen-
presenting cells. Overall, this study shows that APG alters
the phenotype of BMs, increases the viability and
alloreactivity of BMs after gamma radiation both in vitro
and  in vivo. Therefore, APG may be a good candidate
radioprotective agent for BMs.
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Introduction
Panax ginseng is a well-known medicinal herb with
immunomodulatory activity. Its components include water-
soluble factors, polysaccharide, protein, and saponins. An
acidic polysaccharide of Panax ginseng (APG), so called
ginsan is purified from the water extract of Panax ginseng
using column chromatography [13]. NMR spectroscopy
reveals APG to contain glucopyranoside and fructofuranoside.
Since its first purification, APG has been demonstrated to
have anti-tumor [13], radioprotective [20], and immuno-
modulatory effects including macrophage-activating activity
[18].
Gamma radiation is a useful tool for anti-cancer therapy.
However, there can be fatal side effects including the failure
of hematopoietic system and severe immunosuppression.
Therefore, the development of a radioprotective agent is
expected to be an essential part of cancer therapy. Amifostine
is one synthetic compound with radioprotective activity,
providing free thiol in the cells, which acts as a cytoprotectant
upon chemotherapy and radiotherapy [17,21]. However,
clinical trials have revealed amifostine to have serious side
effects [16], which might be related to its synthetic nature. In
addition, there has been an emphasis on developing non-
synthetic, natural product-originated radioprotective agents
due to the few radioprotective agents available.
APG is a candidate therapeutic agent with radioprotective
activity. It was previously reported that APG significantly
enhances the number of hematopoietic and immune cells,
such as bone marrow cells (BMs) and spleen cells, in
irradiated mice [20]. Indeed, APG restored the reduced level
of IFN-gamma [4] and modulated the antioxidant defense
systems [5] in irradiated splenocytes. Thus far, the radioprotective
effect of APG has been attributed to its immunomodulatory
activity. Although APG increases the number of BMs in
irradiated mice, it is unclear if the BMs of APG-treated
irradiated mice are functional. The aim of this study was to
elucidate the phenotypical and functional effects of APG. To
accomplish this, this study examined whether or not a
pretreatment with APG can alter the viability, phenotypical
changes, cytokine production, and alloreactivity of BMs
upon gamma irradiation.
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Materials and Methods
Animals and reagents
C57BL/6 and Balb/c mice were purchased from Orient
BIO (Korea) and maintained in the laboratory animal
facility. 7- to 12 week-old female mice were used for the
experiments. The animal experiments were performed in
accordance with the NIH guidelines (USA) for laboratory
animal use and care. APG was purified by the method as
described in a previous report [13].
Preparation of cells
BMs were harvested by flushing the femurs and tibias of
C57BL/6 mice. The cells were incubated with ammonium
chloride-potassium carbonate (ACK) lysis buffer for 10 min
to lysis red blood cells. The allogeneic CD4
+ T splenocytes
were prepared by mechanically disrupting spleen cells from
Balb/c mice as described elsewhere [7]. The adherent cells
were removed after incubating the splenocytes in RPMI
1640 media containing 10% fetal bovine serum (FBS) for
1 h. The non-adherent cells were harvested by centrifugation
and used for the purification of CD4
+ T lymphocytes using
magnetic beads (Miltenyi Biotec, Germany) according to the
manufacturer’s instruction. All the cells were cultured using
RPMI medium containing FBS, 2 mM L-glutamine, 100 U/
ml penicillin/streptomycin (Invitrogen, USA). Bone marrow-
derived dendritic cells (BMDCs) were generated using the
recombinant mouse granulocyte macrophage-colony stimulating
factor (GM-CSF; Biosource International, USA).
Measurement of cell viability
For the cell viability assays, BMs were seeded at a
concentration of 1 × 10
6 cells/well in a 24-well culture plate,
2×1 0
5 cells/well in a 96-well culture plate. The cells were
treated with APG for 24 h and then irradiated with 1 Gy.
After 24 h, the cell viability was examined using 2 assays.
First, the cells were stained with a trypan blue solution
(Sigma, USA) and the number of viable and dead cells was
counted using an optical microscope. Second, the cells were
incubated in 96-well plate for 48 h and treated with 10 µl/
well of 1 mg/ml 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide (MTT; Sigma, USA) and then 10%
SDS solution for 24 h subsequently. The optical density
(O.D.) of the sample was measured at 570 nm using microplate
reader (Molecular Devices, USA) with 630 nm as a reference.
Mixed leukocyte reaction (MLR)
For MLR assay, a range of cells/well of BMs of C57BL/6
mice and 1 × 10
5 cells/well of CD4
+ T cells of Balb/c mice
were co-cultured in 96-well flat-bottom culture plates (BD
Biosciences, USA). The co-cultures were incubated for 5
days and pulsed with 1 µCi/well 
3H-thymidine (PerkinElmer,
USA). The level of thymidine incorporated was measured
using a liquid scintillation counter (Wallac Microbeta
TriLux; PerkinElmer, USA).
Determination of interleukin (IL)-12 and nitric oxide
production
The IL-12 level was determined by ELISA using CytoSet
antibody pairs (Biosource International, USA) according to
the manufacturer’s protocol. The level of nitric oxide (NO)
was measured by harvesting the culture supernatants after
incubating the BMs in a combination of APG and gamma
irradiation. The cells were removed by centrifugation at
10,000 rpm for 10 sec. The nitrite levels were measured
using a modified Griess reagent (Sigma, USA) according to
the manufacturer’s instructions. Briefly, 50 µl of the culture
supernatant of the BMs was mixed with 50 µl of a modified
Griess reagent at a final concentration of 40 mg/ml. The
O.D. of the mixture was measured at 570 nm. A serial
dilution of sodium nitrite was used as the standard.
Flow cytometry analysis
The cells were washed with a flow cytometry staining
solution, Hanks’ balanced salt solution containing 5% FBS
and 0.1% sodium azide, and incubated with 1 µg/100 µl
each mAb for 30 min at 4
oC. The cells were then stained
with biotin-labeled anti-mouse I-A
b, CD86 and CD11c mAb,
and sequentially with fluorescein isothiocyanate (FITC)- or
phycoerythrin (PE)-streptavidin (BD Biosciences, USA) for
indirect staining. FITC-labeled anti-mouse I-A
b was used
for direct staining. Either FITC- or PE-labeled isotype-
matched mAb was used as the control. The stained cells
were analyzed using a flow cytometer (FACSCaliber;
Becton Dickinson, USA) and software (CellQuest; Becton
Dickinson, USA).
Gamma irradiation
The non-treated or APG-treated BMs were irradiated with
a total dose of 1 Gy using a 
60Co γ-ray source (MDS Nordion
C-188 standard source installed in Applied Radiological
Science Research Institute, Cheju National University, Korea).
In vivo assay
The mice were injected with 100 mg/kg APG and after
24 h, irradiated with 5 Gy. Four days later, BMs were
harvested from the femurs of mice and were counted using
trypan blue exclusion test. The number of BMs was
obtained from one femur of non-irradiated or irradiated mice
and the mean ± SD from 4 femurs. The harvested BMs were
cultured in the presence of 10 ng/ml recombinant mouse
GM-CSF for 7 days. The proportion of DCs was determined
by harvesting the floating cells and staining them with
biotin-labeled anti-CD11c mAb, PE-streptavidin, and FITC-
labeled anti-I-A
b mAb.
Statistical analysis
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a mean ± SD of 3 or 4 independent wells. Most of the data is
representative of 3 individual experiments with similar
results. The statistical significance of the data was evaluated
using Tukey-Kramer multiple comparisons test (Fig. 1-4)
and student’s t-test (Fig. 5). *, **, *** indicate p < 0.05,
0.01, 0.001 respectively.
Results
APG increased the viability of BMs
Trypan blue exclusion test and MTT assay were used to
determine if the APG pretreatment increase the viability of
BMs. In trypan blue exclusion test (Fig. 1A), the viability of
the control BMs treated with the medium alone was 57 ±
3%. In contrast, the viability of the irradiated BMs was 43 ±
9%. APG significantly increased the viability of the BMs
irradiated with gamma radiation. MTT assay showed that
the viability of APG-treated BMs was significantly higher
than the control BMs in the presence or absence of gamma
irradiation (Fig. 1B). Therefore, it is believed that spontaneous
cell death may have occurred in the control BMs in vitro,
and APG appears to increase the viability of control BMs.
Although 0.1 µg/ml APG had little effect, the cell viability
was increased considerably with 1 µg/ml and 10 µg/ml APG
compared with control or irradiated (IR) BMs respectively.
Gamma radiation decreased the viability of BMs and APG
offered significant radioprotection.
BMs treated by APG markedly increased IL-12
production, but not NO
The levels of IL-12, a representative cytokine for cellular
immunity, and nitric oxide (NO), a type of reactive oxygen
species (ROS) with multiple functions, were measured to
determine if APG alters the production of secreted cytokine
and ROS. The APG treatment markedly increased the level
of IL-12 production from BMs, and was not hampered by
gamma radiation (Fig. 2A). However, APG did not
significantly change the level of NO production from BMs
regardless of the presence of gamma radiation (Fig. 2B).
Fig. 1. Acidic polysaccharide of Panax ginseng (APG) increased
the viability of BMs. The cells were seeded in a 24-well culture
plate and treated with 10 µg/ml of APG. After irradiation, trypan
blue exclusion test was performed (A). The cells were seeded i n
a 96-well culture plate and treated with 0-10 µg/ml of APG. After
irradiation, MTT assay was performed (B). All values are
represented as mean ± SD and indicated statistical significance
*p < 0.05 , ***p < 0.001, respectively.
Fig. 2. APG markedly increased IL-12 production in BMs but
not nitric oxide (NO). The cells were seeded and treated wit h
APG as described in Fig. 1A. After gamma irradiation, the cells
were incubated for 24 h and the supernatants were harvested. The
same supernatants were used in the IL-12 (A) and NO (B) assays.
All values are represented as mean ± SD and indicated statistical
significance **p < 0.01, ***p < 0.001, respectively.42 Hyun-Ji Kim et al.
Since gamma radiation decreases the viability of BMs, and
APG protected BMs against gamma radiation, it is unlikely
that the lack of an increase in the NO levels was due to the
altered viability of BMs.
Phenotypical changes of APG-treated BMs based on
flow cytometric analysis
The effect of APG on the phenotypical changes in BMs
was examined by gating the populations of BMs according
to the cell size. After acquiring the data, R1 and R2 (regions)
were gated in the dot plot of each sample (Fig. 3A). R1
contains granulocytes, monocytes, macrophages, dendritic
cells whereas R2 contains dead cells. Indeed, APG significantly
increased the percentage of R1 from 29 ± 2% to 37 ± 2%,
whereas it significantly decreased that of R2 from 23 ± 3%
to 14 ± 4%. The effect of APG on the expression of major
surface molecules, MHC class II and CD86, which are
related to antigen-presenting capability of BMs, was next
examined. APG significantly increased the level of MHC
class II expression from BMs but had no effect on CD86
(Fig. 3B & C).
APG-treated BMs strongly increased the proliferation
of CD4
+ T lymphocytes
Bone marrow is the main source and a reservoir of
hematopoietic cells, and also contains the precursor or
progeny cells of antigen-presenting cells (APCs). This study
evaluated the alloreactivity of BMs in a co-culture with
allogeneic CD4
+ T lymphocytes. APG-treated BMs strongly
stimulated the proliferation of allogeneic CD4
+ T lymphocytes
(Fig. 4). In addition, gamma radiation did not inhibit the
capability of BMs enhanced by APG. The ratio of BMs :
CD4
+ T lymphocytes ranged from 1 : 1 to 1 : 8, and APG-
treated BMs significantly enhanced the proliferation of
allogeneic CD4
+ T lymphocytes at all ratios.
The protection of BMs and DC progenitor cells by
APG from radiation in vivo
Mice were treated with APG and then with gamma
radiation to determine if APG has radioprotective effects on
Fig. 3. The enhanced expression of MHC class II molecules on
the surface of APG-treated BMs. BMs were seeded and treate d
with APG as described in Fig. 1A. The cells were stained as
described in M&M. The cells acquired by flow cytometric
analysis were gated (A) and a representative histogram of eac h
sample is shown (B). The number indicates the mean fluorescence
intensity, minus that of the isotype control. The mean ± SD was
obtained from 3 samples (C). All values are represented as
mean ± SD and indicated statistical significance *** p <0 . 0 0 1 .
Fig. 4. APG increased the proliferation of CD4
+ T lymphocytes.
CD4
+ T lymphocytes of Balb/c mice were co-cultured with BMs
of C57BL/6 mice. After culturing for 5 days, the proliferation o f
CD4
+ T lymphocytes was measured using 
3H-thymidine
incorporation assay. APG-treated BMs significantly increase d
the proliferation of allogeneic CD4
+ T lymphocytes. The result is
representative of 2 experiments. All values are represented as
mean ± SD and indicated statistical significance ** p <0 . 0 1 ,
***p <0 . 0 0 1 .Radioprotective effects of an acidic polysaccharide of  Panax ginseng on bone marrow cells 43
BMs in vivo. The number of BMs harvested from APG-
treated mice 4 days after gamma radiation was significantly
higher than that of the control mice (Fig. 5A). In addition,
the harvested BMs were cultured to generate BMDCs to
determine if the BMs from APG-treated mice have a regular
number of the progenitor cells of BMDCs, which is an
essential antigen-presenting cell type in the immune system.
Flow cytometric analysis revealed the generation of
BMDCs derived from APG-treated mice to be normal (Fig.
5B).
Discussion
Compounds with radioprotective activity from plant- or
marine-originated materials have attracted considerable
attention due to their potential use and lack of toxicity [2, 9].
The compounds purified from ginseng are one group [12,
22]. The ginseng root extract showed radioprotective effects
on the testes of irradiated mice, no changes in the alkaline
phosphatase activity and lipid peroxidation (LPO), whereas
an increase in the acid phosphatase activity and LPO, and a
decrease in the alkaline phosphatase activity have been
observed in irradiated mice [10]. The water extract of Panax
ginseng C.A. Meyer and other active components were
examined for their radioprotective activity in mice based on
several parameters including jejunal crypt survival and the
colony formation of spleen cells [11]. One of the active
components from ginseng, ginsenoside Rg3, also has a
hematopoietic effect by enhancing the proliferation of bone
marrow cells and splenocytes [8].
APG is an active component of ginseng, and has been
shown to have immunomodulatory activity with relative
safety. The drug metabolism of APG and its effects on liver
have been previously examined [19]. Although there
appeared to be marginal difference between males and
females, APG did not show significant hepatic toxicity, and
did not cause any changes in the alanine aminotransferase
and aspartate aminotransferease levels. As an immuno-
modulator, APG significantly decreased the expression of
Toll-like receptor (TLR)-2 and MyD88, an adaptor
molecule for TLR signaling, which was elevated in the
macrophages of mice suffering from sepsis [1]. The anti-
mutagenic effect of APG on bone marrow cells was
compared with those of amifostine [6]. APG reduced the
number of micronucleated polychromatic erythrocytes,
which are usually elevated as a result of gamma radiation.
Although APG was reported to have significant immuno-
modulatory and radioprotective activities [20], there is little
information on the phenotypic alterations or its effect on the
alloreactivity of BMs. This study showed that APG
significantly increases the viability of BMs irradiated with
gamma radiation using trypan blue exclusion test, MTT
assay, and flow cytometric analysis. In addition, APG
altered the phenotypes of BMs, which might be related to its
antigen-presenting function, and increased the proliferation
of allogeneic CD4
+ T lymphocytes.
Gamma radiation alters the regulation of multiple genes
including cytokines [14,15]. It was previously reported that
some cytokines including IL-1, IL-12 stimulated the precursors
of BMs and showed radioprotective and chemoprotective
activity [3]. The results of our study clearly show that APG
increases the level of IL-12 production. It is believed that the
radioprotective effects of APG on BMs might occur through
the IL-12 producing capability of APG. A molecular study
of detailed mechanisms should clarify this.
APG increased the level of MHC class II expression,
which is a major molecule for presenting antigenic peptides,
on the surface of BMs. Furthermore, APG significantly
increased the proliferation of allogeneic CD4
+ T
lymphocytes. This suggests that APG may enhance the
immunomodulatory effects of BMs, at least in part, by
increasing the surface antigen-presenting related molecules.
In addition, the enhancing effect was not inhibited by
gamma radiation. Interestingly, APG did not increase the
level of NO production from BMs whereas it increased the
level of IL-12 in the same supernatants. Although NO plays
Fig. 5. APG significantly increased the number of BMs and DC
progenitor cells in vivo. The mice were injected with PBS alone
or APG, and then irradiated. After 4 days, the number of BMs
obtained from PBS-injected (control) or APG-injected mice was
counted (A) and the cells were cultured in the presence of GM-
CSF to verify the presence of DC progenitor cells. The numbe r
of the dot plot indicates the percentage of CD11c and MHC II
double positive cells (B). Result is a representative of 2
individual experiments. All values are represented as mean ± SD
and indicated statistical significance ***p <0 . 0 0 1 .44 Hyun-Ji Kim et al.
a role in the phagocytosis of macrophages, it has also
inhibitory effects on the antigen-presenting capability of
APCs, and acts as a potential mediator of the inflammatory
process. Therefore, the lack of a significant increase in NO
by APG might have both positive and negative implications
for the immune responses.
Overall, APG increases the viability of BMs both in vitro
and in vivo, which was not suppressed by gamma radiation.
These results highlight the potential of APG as a
radioprotective agent, at least for prophylactic purposes.
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